Literature DB >> 1688485

Palliative operations for pancreatic carcinoma.

J R Potts1, T A Broughan, R E Hermann.   

Abstract

Controversies in palliation of pancreatic carcinoma include the best biliary bypass, the best gastric by-pass, and how routinely gastric bypass should be used. We reviewed the records of 142 patients who underwent palliative operations for pancreatic carcinoma at the Cleveland Clinic over a 5-year period. Direct choledochal-enteric anastomosis proved superior to cholecystojejunostomy because of the high incidence of postoperative biliary sepsis and obstruction with the latter. The lowest incidence of these complications was achieved with choledochoduodenostomy. Loop gastrojejunostomy and Roux-Y gastrojejunostomy resulted in similar complication rates and postoperative stays, but, because loop reconstruction was simpler, it was deemed superior. Blood loss, operative time, and hospital stay were similar in patients with loop gastrojejunostomy and patients with no gastric bypass. This finding, coupled with a 10% incidence of subsequent gastric outlet obstruction in those without gastric bypass, indicates that gastric bypass should be liberally applied in the palliation of pancreatic carcinoma.

Entities:  

Mesh:

Year:  1990        PMID: 1688485     DOI: 10.1016/s0002-9610(05)80609-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Surgical treatment of pancreatic cancer. The United States experience.

Authors:  E H Livingston; M L Welton; H A Reber
Journal:  Int J Pancreatol       Date:  1991

2.  Primary sarcoma of the pancreas, a rare histopathological entity. A case report with review of literature.

Authors:  Peter Ambe; Christian Kautz; Shawqi Shadouh; Silvia Heggemann; Lothar Köhler
Journal:  World J Surg Oncol       Date:  2011-08-03       Impact factor: 2.754

Review 3.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

4.  Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial.

Authors:  K D Lillemoe; J L Cameron; H S Kaufman; C J Yeo; H A Pitt; P K Sauter
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

5.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

6.  Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer.

Authors:  G V Raikar; M M Melin; A Ress; S Z Lettieri; J J Poterucha; D M Nagorney; J H Donohue
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

7.  Surgical palliation for pancreatic malignancy: practice patterns and predictors of morbidity and mortality.

Authors:  Edmund K Bartlett; Heather Wachtel; Douglas L Fraker; Charles M Vollmer; Jeffrey A Drebin; Rachel R Kelz; Giorgos C Karakousis; Robert E Roses
Journal:  J Gastrointest Surg       Date:  2014-03-27       Impact factor: 3.452

8.  Palliative surgical bypass for pancreatic and peri-ampullary cancers.

Authors:  Samrat Mukherjee; Hemant M Kocher; Robert R Hutchins; Satyajit Bhattacharya; Ajit T Abraham
Journal:  J Gastrointest Cancer       Date:  2007

9.  Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas.

Authors:  R P van den Bosch; G P van der Schelling; J H Klinkenbijl; P G Mulder; M van Blankenstein; J Jeekel
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

10.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.